{
    "2020-12-02": [
        [
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)披露定增报告书：鹏华基金、银华基金、UBS AG及J.P.Morgan等均参投",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "定增",
                        "鹏华基金",
                        "银华基金",
                        "UBS AG",
                        "J.P.Morgan"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|周报】如何选股？创新赋能、制造升级和降本增效",
                "features": {
                    "keywords": [
                        "浙商医药",
                        "周报",
                        "选股",
                        "创新赋能",
                        "制造升级",
                        "降本增效"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}